Press release
Organoids Market Insights Highlight Segment Expansion And Market Leadership
Organoids Market
Predicted Market Expansion of the Organoids Market by 2030
The organoids market is set to experience substantial growth over the coming years, reaching a valuation of $13.13 billion by 2030. This expansion is driven by a compound annual growth rate (CAGR) of 22.2%. Several factors contribute to this surge, including the widening use of personalized medicine, increasing collaborations between pharmaceutical firms and organoid research companies, and active growth in regenerative medicine initiatives. Additionally, heightened government and private funding for organoid-related research, along with the establishment of organoid biobanks for disease modeling, play crucial roles. Important trends expected during this period include the broader adoption of organoids in drug discovery and personalized treatments, expanded applications in tissue engineering and regenerative medicine, increased use in studying infectious disease pathology, development of disease-specific organoids for tailored therapies, and enhanced integration of organoid models in preclinical testing for drug efficacy and toxicity.
The organoids market size has grown exponentially in recent years. It will grow from $4.82 billion in 2025 to $5.9 billion in 2026 at a compound annual growth rate (CAGR) of 22.3%. The growth in the historic period can be attributed to advancements in stem cell technology, rising demand for alternative models to animal testing, increasing research in tissue engineering, growing investments in biotechnology R&D, early adoption of organoid models by academic research institutes.
Download a free sample of the organoids market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10787&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR
Leading Organizations Driving the Organoids Industry
The organoids market features a diverse group of prominent companies, including Cellesce Ltd., STEMCELL Technologies, HUB Organoids, DefiniGEN, OcellO B.V., Organoid Therapeutics, InSphero AG, Axol Bioscience Ltd., TissUse GmbH, Epithelix Sàrl, SUN Bioscience, Prellis Biologics, Epistem, MIMETAS BV, Organoidsciences Ltd., Zenit Science, Biomorgan, TheWell Bioscience Inc., CN Bio Innovations Ltd., TARA Biosystems, Nortis Inc., Newcells Biotech, Known Medicine, Dynomics Inc., CHA Biotech Co Ltd, and Tempus AI Inc.
A notable development occurred in December 2024, when Germany-based life sciences firm Merck KGaA acquired HUB Organoids Holding B.V., a Netherlands-based company specializing in organoid technologies and foundational patents in organoid biology. This strategic acquisition aims to broaden Merck's next-generation biology portfolio by incorporating HUB Organoids' proprietary technologies, including model creation, assay development, and high-throughput screening capabilities.
Emerging Innovations and Opportunities in the Organoids Market
Industry leaders are focusing heavily on creating groundbreaking platforms to accelerate drug discovery and enhance competitive positioning. One such innovation is the development of organoid panel screening platforms, which enable simultaneous testing across a collection of organoids to expedite preclinical oncology research.
For example, in November 2023, Crown Bioscience, a US-based contract research organization and part of JSR Life Sciences, introduced OrganoidXplore-a large-scale organoid panel screening platform designed to speed up preclinical oncology drug discovery. Utilizing Crown Bioscience's exclusive assay-ready organoid technology, OrganoidXplore offers highly reliable results, faster project completion, and cost savings compared to conventional approaches. This platform significantly advances preclinical drug screening by accurately replicating the tumor's original genomic, morphological, and pathophysiological characteristics, thus enabling more dependable drug response comparisons.
View the full organoids market report:
https://www.thebusinessresearchcompany.com/report/organoids-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR
Detailed Segmentation of the Global Organoids Market
This report categorizes the organoids market based on product types, applications, and regions.
By Product, the market includes Hepatic Organoids, Colorectal Organoids, Intestinal Organoids, and Other Products.
Applications cover Developmental Biology, Disease Pathology of Infectious Disease, Regenerative Medicine, Drug Toxicity and Efficacy Testing, Drug Discovery and Personalized Medicine, along with Other Applications.
End-users are classified as Hospitals and Diagnostic Centers, Biotechnology and Pharmaceutical Companies, and Other End-Users.
Further subcategories consist of:
- Hepatic Organoids: Hepatic Stem Cell-Derived, Primary Liver Cell-Derived, and Liver Tumor Organoids
- Colorectal Organoids: Colonic, Rectal, and Colorectal Cancer Organoids
- Intestinal Organoids: Small Intestinal, Enteroid, and Intestinal Stem Cell-Derived Organoids
- Other Products: Pancreatic, Brain, Kidney, and Lung Organoids
This comprehensive segmentation enables a deeper understanding of the market's composition and the specific niches that drive innovation and demand across the organoid landscape.
Expanded capabilities in our 2026 market reports:
• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Organoids Market Insights Highlight Segment Expansion And Market Leadership here
News-ID: 4611414 • Views: …
More Releases from The Business Research Company
Oral Mucositis Market Report Evaluates Growth Drivers, Challenges And Market Dyn …
Exploring the oral mucositis market reveals promising growth driven by advances in cancer supportive care and increasing awareness of this painful condition. As oncology treatments evolve, the market is responding with innovative therapies and devices aimed at improving patient outcomes. Let's delve into the market's size, leading players, emerging trends, and key segments shaping its future.
Projected Growth and Market Size of the Oral Mucositis Industry
The oral mucositis market…
Oral Care Market Report Provides Insights Into Market Evolution And Growth Prosp …
The oral care industry is on track for substantial growth as consumer awareness and product innovation continue to drive demand. With a rising focus on oral health and preventive care, the market is evolving rapidly, opening up new opportunities for brands and consumers alike. Let's explore the expected market size, key players, trends, and segment breakdowns shaping the future of this vital sector.
Forecasted Growth and Value of the Oral Care…
Optic Neuropathy Management Market Research Explores Growth Within A $5.07 Billi …
The optic neuropathy management market is poised for significant expansion in the coming years, driven by advances in treatment options and growing clinical adoption of innovative therapies. As research progresses and patient care improves, this sector is expected to undergo notable changes that will reshape how optic nerve disorders are diagnosed and treated. Let's explore the current market outlook, key players, emerging trends, and the major segments fueling growth in…
Opioid-Induced Constipation Treatment Market Analysis Highlights Growth To $2.54 …
The opioid-induced constipation treatment market is set to expand significantly as the demand for innovative therapies grows. Various factors, including rising opioid use and advances in targeted medications, are propelling this market toward promising prospects. Below, we explore the market size, key players, trends, and segmentation for a clearer understanding of its future trajectory.
Opioid-Induced Constipation Treatment Market Size and Growth Outlook
The market for opioid-induced constipation (OIC) treatments is…
More Releases for Organoid
Advancing Human Hair Research with Skin Organoid Models
Hair research plays a critical role in addressing common conditions such as androgenetic alopecia, hair thinning, and hair graying. Yet, despite decades of study, the development of effective therapies has been slow. One major reason is the limited ability of conventional research models to accurately reflect the complexity of human hair follicle biology.
Recent advances in human skin organoid technology are reshaping this landscape. Skin organoids provide a three-dimensional, human-relevant platform…
4Dcell Achieves 95% Organoid Reproducibility Breakthrough With Patented Anchorin …
4Dcell announced that its SmartSphero plates have achieved over 95% reproducibility in organoid size and shape, while reducing organoid loss during medium exchanges to below 12%, a significant improvement over the 86% loss seen in traditional unanchored systems. This breakthrough addresses a persistent challenge in pharmaceutical drug screening and safety testing, where inconsistent organoid cultures have often hindered data reliability.
The company's patented Anchoring Point Technology (APT®) allows researchers to culture…
Organoid Culture Medium Research:the global Organoid Culture Medium market size …
QY Research Inc. (Global Market Report Research Publisher) announces the release of 2025 latest report "Organoid Culture Medium- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031". Based on current situation and impact historical analysis (2020-2024) and forecast calculations (2025-2031), this report provides a comprehensive analysis of the global Wire Drawing Dies market, including market size, share, demand, industry development status, and forecasts for the next few years.
…
Organoid Technology Market Size, Growth, In-depth Analysis, Research Report Fore …
The organoid technology market is estimated to grow at a CAGR of 27.12% during the forecast period.
The prime factors propelling the growth of the organoid technology market are increasing demand for personalized medicine, drug discovery and development, and regenerative medicine.
As per the report, the organoid technology market is expected to grow rapidly during the forecast period.
Organoids are three-dimensional cell cultures that mimic the structure and function of human organs, making…
Organoid Technology Market Trends, Future Demands, Growth Factors, Emerging Tech …
The global Organoids and Spheroids Market size was valued at $516.6 million in 2021 and is projected to reach $1.2 billion by 2031, growing at a CAGR of 8.5% from 2022 to 2031.
Organoid technology bridges the gap between conventional two-dimensional cell line culture and in vivo models. The near-physiological technology can virtually recapitulates organ development and human diseases, such as infectious diseases, genetic abnormality and even cancers.
Between traditional two-dimensional cell…
Organoids Market Driven By Definigen, Organoid Therapeutics, Hubrecht Organoid T …
The scope of the organoids market includes type, application, source, and region. The organoids market is analyzed based on regions, such as North America, Europe, Asia Pacific, Middle East & Africa, and South and Central America. The report offers insights and in-depth analysis of the organoids market emphasizing on various parameters, such as market trends, technological advancements, market dynamics, and competitive landscape analysis of leading market players across the globe.…
